The study will determine the safety and efficacy of a new human - non pancreatic phospholipase A2 inhibitor in the treatment of severe sepsis. We expect the drug to improve survival and decrease the incidence of multiorgan dysfunction.
Showing the most recent 10 out of 565 publications